We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




Robotic System Facilitates Cochlear Implant Insertion

By HospiMedica International staff writers
Posted on 20 Oct 2021
New cochlear implant insertion technology aids surgeons in placement of electrode arrays by controlling insertion speed. More...


The iotaMotion (Iowa City, USA) iotaSOFT Insertion System is a small, thumb-sized, open platform robotic technology compatible with a variety of implants, which fits seamlessly into existing surgical workflows. The bone-mounted robotic device aids the surgeon during insertion of the implant electrode array by reducing insertion variability and undesirable forces. However, the surgeon still controls the precise motion capabilities of the robotic-assisted insertion, using technical skills, training, and experience.

According to iotaMotion, when inserting cochlear implants manually, the amount of force used can spike as the electrode is pushed through the final millimeters across the sensitive areas of the ear; as a result, an estimated 15-50% of all people who receive a cochlear implant have reported additional losses of their natural hearing. By slowing down the speed of the procedure and giving the surgeon added control, iotaSOFT aims to limit the amount of damage caused to the delicate cochlea by the surgery itself, helping to maintain the patient’s residual hearing.

“Historically, cochlear implant electrode arrays have been placed solely by hand with forceps and other manual instrumentation. With the advent of robotic-assisted systems like the iotaSOFT, we will now have the ability to place the electrode into the delicate, tiny structures of the cochlea with the added precision and stability that robotic assistance provides,” said Marlan Hansen, MD, medical Director iotaMotion. “There are clear opportunities to improve outcomes, optimize preservation of existing function, and support consistent results for surgeons and patients in the US and around the world.”

In a normal ear, sound vibrations in the air lead to resonant vibrations of the basilar membrane inside the cochlea. The movement of hair cells, located all along the basilar membrane, creates an electrical disturbance that can be picked up by the surrounding nerve cells, allowing the brain to interpret the nerve activity and determine what sound frequency is being heard. The cochlear implant bypasses the hair cells and stimulates the cochlear nerves directly using electrical impulses. This allows the brain to interpret the frequency of sound as it would if the hair cells of the basilar membrane were functioning properly.

Related Links:
iotaMotion


Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
New
Complete Hip System
Taperloc Complete Hip System
New
Needle Guide Disposable Kit
Verza
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The new AI-based method can predict treatment outcomes from health record data (Photo courtesy of 123RF)

AI Tool Accurately Sorts Cancer Patients by Likely Outcomes

Pharmaceutical companies and healthcare providers often face the challenge of determining which patients will respond most effectively to a given drug. A new artificial intelligence (AI)-based method has... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.